Irinotecan (Camptosar) in Patients With Advanced Sarcomas
NCT00509860
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
Irinotecan
Sponsor
M.D. Anderson Cancer Center